Volume 66, Issue 6, Pages (December 2015)

Slides:

Advertisements

Similar presentations

Acute myocardial infarction as presentation of an infiltrative lung neoplasia Aitor Uribarri, MD, Adolfo Villa, MD, Gerard Loughlin, MD, Francisco Fernández-Avilés,

Advertisements

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Prolonged survival after surgery for cardiac metastasis from malignant melanoma Antoine Noel, intern, Claire Toquet, MD, Jacques Dewilde, MD Journal of.

Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of B-type natriuretic peptide in the diagnosis.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: N-terminal pro brain natriuretic peptide on admission.

Volume 64, Issue 6, Pages (December 2014)

Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K

Volume 69, Issue 2, Pages (February 2017)

Blood lactate level during extracorporeal life support as a surrogate marker for survival Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,

Preprocedural high-sensitive troponin predicts survival after transcatheter aortic valve implantation (TAVI) Derk Frank, Sophia Stark, Matthias Lutz,

Sutureless aortic valve replacement may improve early mortality compared with transcatheter aortic valve implantation: A meta-analysis of comparative.

Optimal Noninvasive Assessment of Diastolic Heart Failure in Patients with Atrial Fibrillation: Comparison of Tissue Doppler Echocardiography, Left Atrium.

B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,

Figure 1 Flow diagram displaying the proportions of patients with troponin measurements available from all eligible patients and the resulting study population.

Exercise Capacity and Heart Rate Responses to Exercise as Predictors of Short-Term Outcome Among Patients With Stable Coronary Artery Disease Antti M.

Tight Blood Glucose Control With Insulin in the ICU

Volume 69, Issue 1, Pages (January 2017)

Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study

The relationship of angiographically defined coronary artery disease with insulin sensitivity and secretion in subjects with different glucose tolerance

Volume 67, Issue 1, Pages (January 2016)

Volume 55, Issue 3, Pages (May 2010)

Volume 61, Issue 4, Pages (April 2013)

Volume 66, Issue 4, Pages (October 2015)

Frontiers of anticoagulation therapy for atrial fibrillation

Volume 64, Issue 3, Pages (September 2014)

Volume 66, Issue 5, Pages (November 2015)

Volume 60, Issue 4, Pages (October 2012)

Volume 66, Issue 3, Pages (September 2015)

Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,

Significance of Elevated Cardiac Troponin T Levels in Critically Ill Patients with Acute Respiratory Disease Vlad C. Vasile, MD, PhD, High-Seng Chai,

B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain Philip Haaf, MD, Tobias Reichlin, MD, Nils Corson, MD,

Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer Lee.

B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer

Prognostic Value of Low Blood Glucose at the Presentation of E

A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both Nadia Aissaoui, Edith Martins,

N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery

Survival Prediction of Patients with Advanced Cancer: The Predictive Accuracy of the Model Based on Biological Markers Nobutaka Kikuchi, MD, Kaori Ohmori,

Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis Chalotte Winther Nicolajsen, MD, Maja.

Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis Tsung-Yu Tsai, MD, Yu-Chen Huang, MD Journal.

Blood lactate level during extracorporeal life support as a surrogate marker for survival Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,

Ian S. Currie, BSc, MBChB, MD, PhD, Sonia J

Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndromes: Troponin Alone Is not Enough Philippe Gabriel Steg, Gordon FitzGerald, Keith.

Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.

Volume 146, Issue 6, Pages (December 2014)

Endurance exercise-induced changes in BNP concentrations in cardiovascular patients versus healthy controls Vincent L. Aengevaeren, Maria T.E. Hopman,

Nicholas Wettersten, MD, Alan S. Maisel, MD

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Mortality rates and walking ability transition after lower limb major amputation in hemodialysis patients Fukashi Serizawa, MD, PhD, Shigeru Sasaki,

N-terminal pro B-type natriuretic peptide (NT pro-BNP) is a predictor of long-term survival in male patients of 75 years and older with high-grade asymptomatic.

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Mixed venous oxygen saturation predicts short- and long-term outcome after coronary artery bypass grafting surgery: a retrospective cohort analysis J.

Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung.

International Journal of Cardiology

C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization Patrick A. Stone,

The Simplified Acute Physiology Score II as a Predictor of Mortality in Patients Who Underwent Extracorporeal Membrane Oxygenation for Septic Shock Myung.

Validation of pulse pressure variation and corrected flow time as predictors of fluid responsiveness in patients in the prone position S.-Y. Yang, J.-K.

A. Mekontso-Dessap, L. Tual, M. Kirsch, G. D'Honneur, D. Loisance, L

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Circulating Serum Vascular Endothelial Growth Factor is Not a Prognostic Factor of Non-small Cell Lung Cancer Mohammad Chakra, MD, Jean Louis Pujol,

Volume 71, Issue 6, Pages (March 2007)

Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,

Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non- small Cell Lung Cancer Takeshi Hanagiri, MD, PhD, Kenji Sugio, MD,

Quantitative real-time PCR and the (1 → 3)-β-d-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization Y. Matsumura,

C. J. Payne, S. C. Gibson, G. Bryce, A. G. Jardine, C. Berry, D. B

Joshua R. Smith, Erik H. Van Iterson, Bruce D. Johnson, Barry A

Stavros V. Konstantinides et al. JACC 2017;69:

Physical Function in Patients with Cancer

Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma Hirofumi Uehara, MD,

Presentation transcript:

Volume 66, Issue 6, Pages 460-465 (December 2015) Predictive value of biomarkers for the prognosis of acute pulmonary embolism in Japanese patients: Results of the Tokyo CCU Network registry Yasuhiro Tanabe, MD, Toru Obayashi, MD, PhD, Takeshi Yamamoto, MD, PhD, Morimasa Takayama, MD, PhD, Ken Nagao, MD, PhD Journal of Cardiology Volume 66, Issue 6, Pages 460-465 (December 2015) DOI: 10.1016/j.jjcc.2015.03.002 Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 1 Study population. Between 2009 and 2011, 601 consecutive patients with acute pulmonary embolism were treated at institutions of the Tokyo CCU Network and registered by survey-forms. Of these, 160 cases were excluded because of insufficient information. Therefore, 441 cases were enrolled in this study. BNP, B-type natriuretic peptide. Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 2 Thirty-day mortality according to severity. The 30-day mortality rates according to severity were 1.8% (5/279) among non-massive type cases, 5.5% (6/109) among sub-massive type cases, 22.9% (8/35) among massive-type cases, and 44.4% (8/18) among collapse-type cases. Increases in the 30-day mortality were directly proportional to increases in pulmonary embolism severity (p<0.001). Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 3 BNP levels and 30-day mortality. Regarding all-cause, 30-day mortality, the median BNP level of the 30-day mortality group (n=10) was 545.0pg/mL (25th to 75th interquartile range: 169.8–761.2pg/mL), which was significantly higher than the median level of 181.6pg/mL (25th to 75th interquartile range: 45.2–464.0pg/mL) in the surviving group (n=200; p=0.016). BNP, B-type natriuretic peptide. Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 4 Receiver operating characteristic curve analysis for assessing the capacity of BNP to predict 30-day mortality provided an AUC of 0.73 (p=0.016; 95% confidence interval, 0.589–0.862). AUC, area under the curve. BNP, B-type natriuretic peptide. Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 5 Troponin status and 30-day mortality. The 30-day mortality rate for troponin-positive cases was 10.3%; this value was significantly higher than the rate of 2.1% for negative cases (p=0.017). Additionally, regarding 30-day mortality, the troponin positivity test had a sensitivity, specificity, positive predictive value, and negative predictive value of 66.7%, 73.3%, 10.3%, and 97.9%, respectively. Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 6 Blood glucose levels at admission and 30-day mortality. Among the 224 patients with blood glucose levels at admission between 70 and <150mg/dL, 8 (3.6%) died within 30 days, which was significantly lower than that of 11 (10.3%) among the 107 patients with glucose levels ≥150mg/dL (p=0.021). Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 7 Receiver operating characteristic curve analysis for assessing the capacity of blood glucose to predict 30-day mortality provided an AUC of 0.67 (p=0.013; 95% confidence interval, 0.560–0.781). AUC, area under the curve. Journal of Cardiology 2015 66, 460-465DOI: (10.1016/j.jjcc.2015.03.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions